nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—Menopause—Procarbazine—brain cancer	0.0445	0.0597	CcSEcCtD
Terazosin—KCNH6—ganglion—brain cancer	0.0396	0.155	CbGeAlD
Terazosin—KCNH6—telencephalon—brain cancer	0.0153	0.0599	CbGeAlD
Terazosin—KCNH7—head—brain cancer	0.0134	0.0524	CbGeAlD
Terazosin—KCNH7—central nervous system—brain cancer	0.0122	0.0478	CbGeAlD
Terazosin—KCNH7—cerebellum—brain cancer	0.0119	0.0467	CbGeAlD
Terazosin—Osteoarthritis—Lomustine—brain cancer	0.0116	0.0155	CcSEcCtD
Terazosin—KCNH7—brain—brain cancer	0.00968	0.038	CbGeAlD
Terazosin—ADRA1A—hindbrain—brain cancer	0.00956	0.0375	CbGeAlD
Terazosin—KCNH6—head—brain cancer	0.00952	0.0373	CbGeAlD
Terazosin—KCNH6—central nervous system—brain cancer	0.00869	0.0341	CbGeAlD
Terazosin—ADRA1D—telencephalon—brain cancer	0.00847	0.0332	CbGeAlD
Terazosin—Photosensitivity—Procarbazine—brain cancer	0.00835	0.0112	CcSEcCtD
Terazosin—Visual impairment—Lomustine—brain cancer	0.0077	0.0103	CcSEcCtD
Terazosin—Speech disorder—Carmustine—brain cancer	0.00735	0.00986	CcSEcCtD
Terazosin—Speech disorder—Temozolomide—brain cancer	0.0071	0.00953	CcSEcCtD
Terazosin—KCNH6—brain—brain cancer	0.0069	0.0271	CbGeAlD
Terazosin—Laryngospasm—Etoposide—brain cancer	0.00655	0.00879	CcSEcCtD
Terazosin—Coordination abnormal—Carmustine—brain cancer	0.00644	0.00864	CcSEcCtD
Terazosin—Neck pain—Carmustine—brain cancer	0.0064	0.00859	CcSEcCtD
Terazosin—Coordination abnormal—Temozolomide—brain cancer	0.00622	0.00835	CcSEcCtD
Terazosin—Musculoskeletal pain—Temozolomide—brain cancer	0.00618	0.0083	CcSEcCtD
Terazosin—Angina pectoris—Procarbazine—brain cancer	0.00618	0.00829	CcSEcCtD
Terazosin—Urinary incontinence—Carmustine—brain cancer	0.0061	0.00819	CcSEcCtD
Terazosin—Urinary incontinence—Temozolomide—brain cancer	0.0059	0.00792	CcSEcCtD
Terazosin—Pollakiuria—Procarbazine—brain cancer	0.00586	0.00786	CcSEcCtD
Terazosin—Photosensitivity reaction—Procarbazine—brain cancer	0.00579	0.00777	CcSEcCtD
Terazosin—Thrombocytopenia—Lomustine—brain cancer	0.00556	0.00746	CcSEcCtD
Terazosin—Pain—Carboplatin—brain cancer	0.00555	0.00745	CcSEcCtD
Terazosin—Abnormal vision—Carmustine—brain cancer	0.00551	0.0074	CcSEcCtD
Terazosin—Jaundice—Procarbazine—brain cancer	0.00551	0.0074	CcSEcCtD
Terazosin—Face oedema—Hydroxyurea—brain cancer	0.00548	0.00736	CcSEcCtD
Terazosin—ADRA1A—brainstem—brain cancer	0.00548	0.0215	CbGeAlD
Terazosin—Sweating—Procarbazine—brain cancer	0.00542	0.00727	CcSEcCtD
Terazosin—Anorexia—Lomustine—brain cancer	0.00541	0.00726	CcSEcCtD
Terazosin—ADRA1B—head—brain cancer	0.00539	0.0211	CbGeAlD
Terazosin—ADRA1D—endocrine gland—brain cancer	0.00534	0.0209	CbGeAlD
Terazosin—Epistaxis—Procarbazine—brain cancer	0.00533	0.00716	CcSEcCtD
Terazosin—Abnormal vision—Temozolomide—brain cancer	0.00533	0.00715	CcSEcCtD
Terazosin—ADRA1D—head—brain cancer	0.00527	0.0207	CbGeAlD
Terazosin—Body temperature increased—Carboplatin—brain cancer	0.00513	0.00689	CcSEcCtD
Terazosin—Decreased appetite—Lomustine—brain cancer	0.00494	0.00663	CcSEcCtD
Terazosin—ADRA1B—central nervous system—brain cancer	0.00492	0.0193	CbGeAlD
Terazosin—Nasal congestion—Temozolomide—brain cancer	0.00487	0.00653	CcSEcCtD
Terazosin—ADRA1A—telencephalon—brain cancer	0.00486	0.0191	CbGeAlD
Terazosin—ADRA1D—central nervous system—brain cancer	0.00481	0.0189	CbGeAlD
Terazosin—KCNH2—telencephalon—brain cancer	0.0047	0.0184	CbGeAlD
Terazosin—Dysuria—Hydroxyurea—brain cancer	0.00459	0.00616	CcSEcCtD
Terazosin—Arrhythmia—Procarbazine—brain cancer	0.00453	0.00608	CcSEcCtD
Terazosin—Body temperature increased—Lomustine—brain cancer	0.00449	0.00602	CcSEcCtD
Terazosin—Weight increased—Hydroxyurea—brain cancer	0.00447	0.00599	CcSEcCtD
Terazosin—Face oedema—Carmustine—brain cancer	0.00443	0.00595	CcSEcCtD
Terazosin—Tension—Procarbazine—brain cancer	0.00433	0.00582	CcSEcCtD
Terazosin—Nervousness—Procarbazine—brain cancer	0.00429	0.00576	CcSEcCtD
Terazosin—Face oedema—Temozolomide—brain cancer	0.00428	0.00575	CcSEcCtD
Terazosin—ABCB1—blood vessel—brain cancer	0.00425	0.0167	CbGeAlD
Terazosin—Hypokalaemia—Carmustine—brain cancer	0.00418	0.00561	CcSEcCtD
Terazosin—Tremor—Procarbazine—brain cancer	0.00414	0.00555	CcSEcCtD
Terazosin—Hypokalaemia—Temozolomide—brain cancer	0.00404	0.00542	CcSEcCtD
Terazosin—Syncope—Procarbazine—brain cancer	0.00396	0.00532	CcSEcCtD
Terazosin—ADRA1B—brain—brain cancer	0.00391	0.0153	CbGeAlD
Terazosin—Loss of consciousness—Procarbazine—brain cancer	0.00388	0.00521	CcSEcCtD
Terazosin—Cough—Procarbazine—brain cancer	0.00385	0.00517	CcSEcCtD
Terazosin—Convulsion—Procarbazine—brain cancer	0.00383	0.00514	CcSEcCtD
Terazosin—KCNH2—pituitary gland—brain cancer	0.00382	0.015	CbGeAlD
Terazosin—ADRA1D—brain—brain cancer	0.00382	0.015	CbGeAlD
Terazosin—Arthralgia—Procarbazine—brain cancer	0.00376	0.00505	CcSEcCtD
Terazosin—Myalgia—Procarbazine—brain cancer	0.00376	0.00505	CcSEcCtD
Terazosin—Anxiety—Procarbazine—brain cancer	0.00375	0.00503	CcSEcCtD
Terazosin—KCNH2—medulla oblongata—brain cancer	0.00369	0.0145	CbGeAlD
Terazosin—Bronchitis—Temozolomide—brain cancer	0.00369	0.00495	CcSEcCtD
Terazosin—Dry mouth—Procarbazine—brain cancer	0.00368	0.00494	CcSEcCtD
Terazosin—Anaphylactoid reaction—Etoposide—brain cancer	0.00367	0.00492	CcSEcCtD
Terazosin—Cardiac failure—Etoposide—brain cancer	0.00364	0.00488	CcSEcCtD
Terazosin—Confusional state—Procarbazine—brain cancer	0.00364	0.00488	CcSEcCtD
Terazosin—Vomiting—Lomustine—brain cancer	0.00361	0.00485	CcSEcCtD
Terazosin—Oedema—Procarbazine—brain cancer	0.00361	0.00484	CcSEcCtD
Terazosin—Dysuria—Temozolomide—brain cancer	0.00358	0.00481	CcSEcCtD
Terazosin—Shock—Procarbazine—brain cancer	0.00355	0.00476	CcSEcCtD
Terazosin—Pollakiuria—Temozolomide—brain cancer	0.00354	0.00475	CcSEcCtD
Terazosin—Erectile dysfunction—Temozolomide—brain cancer	0.00353	0.00474	CcSEcCtD
Terazosin—Thrombocytopenia—Procarbazine—brain cancer	0.00353	0.00474	CcSEcCtD
Terazosin—Depression—Carmustine—brain cancer	0.00353	0.00473	CcSEcCtD
Terazosin—Tachycardia—Procarbazine—brain cancer	0.00352	0.00472	CcSEcCtD
Terazosin—Photosensitivity reaction—Temozolomide—brain cancer	0.0035	0.0047	CcSEcCtD
Terazosin—Weight increased—Temozolomide—brain cancer	0.00349	0.00468	CcSEcCtD
Terazosin—Hyperhidrosis—Procarbazine—brain cancer	0.00349	0.00468	CcSEcCtD
Terazosin—Urinary tract infection—Carmustine—brain cancer	0.00344	0.00461	CcSEcCtD
Terazosin—Anorexia—Procarbazine—brain cancer	0.00344	0.00461	CcSEcCtD
Terazosin—Depression—Temozolomide—brain cancer	0.00341	0.00457	CcSEcCtD
Terazosin—Nausea—Lomustine—brain cancer	0.00337	0.00453	CcSEcCtD
Terazosin—KCNH2—midbrain—brain cancer	0.00337	0.0132	CbGeAlD
Terazosin—Hypotension—Procarbazine—brain cancer	0.00337	0.00452	CcSEcCtD
Terazosin—Urinary tract infection—Temozolomide—brain cancer	0.00332	0.00446	CcSEcCtD
Terazosin—KCNH2—spinal cord—brain cancer	0.00329	0.0129	CbGeAlD
Terazosin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00328	0.00441	CcSEcCtD
Terazosin—Insomnia—Procarbazine—brain cancer	0.00326	0.00438	CcSEcCtD
Terazosin—Paraesthesia—Procarbazine—brain cancer	0.00324	0.00434	CcSEcCtD
Terazosin—Sinusitis—Temozolomide—brain cancer	0.00321	0.0043	CcSEcCtD
Terazosin—Somnolence—Procarbazine—brain cancer	0.0032	0.0043	CcSEcCtD
Terazosin—Ill-defined disorder—Hydroxyurea—brain cancer	0.00317	0.00426	CcSEcCtD
Terazosin—Decreased appetite—Procarbazine—brain cancer	0.00313	0.00421	CcSEcCtD
Terazosin—Oedema peripheral—Carmustine—brain cancer	0.00313	0.0042	CcSEcCtD
Terazosin—Fatigue—Procarbazine—brain cancer	0.00311	0.00417	CcSEcCtD
Terazosin—Malaise—Hydroxyurea—brain cancer	0.00308	0.00414	CcSEcCtD
Terazosin—Constipation—Procarbazine—brain cancer	0.00308	0.00414	CcSEcCtD
Terazosin—Pain—Procarbazine—brain cancer	0.00308	0.00414	CcSEcCtD
Terazosin—ADRA1A—endocrine gland—brain cancer	0.00307	0.012	CbGeAlD
Terazosin—Visual impairment—Carmustine—brain cancer	0.00306	0.00411	CcSEcCtD
Terazosin—Pharyngitis—Temozolomide—brain cancer	0.00304	0.00409	CcSEcCtD
Terazosin—ADRA1A—head—brain cancer	0.00303	0.0119	CbGeAlD
Terazosin—Oedema peripheral—Temozolomide—brain cancer	0.00302	0.00406	CcSEcCtD
Terazosin—Feeling abnormal—Procarbazine—brain cancer	0.00297	0.00399	CcSEcCtD
Terazosin—Eye disorder—Carmustine—brain cancer	0.00297	0.00398	CcSEcCtD
Terazosin—KCNH2—endocrine gland—brain cancer	0.00296	0.0116	CbGeAlD
Terazosin—Convulsion—Hydroxyurea—brain cancer	0.00296	0.00398	CcSEcCtD
Terazosin—Visual impairment—Temozolomide—brain cancer	0.00296	0.00397	CcSEcCtD
Terazosin—Gastrointestinal pain—Procarbazine—brain cancer	0.00295	0.00396	CcSEcCtD
Terazosin—KCNH2—head—brain cancer	0.00292	0.0115	CbGeAlD
Terazosin—Discomfort—Hydroxyurea—brain cancer	0.00288	0.00386	CcSEcCtD
Terazosin—Eye disorder—Temozolomide—brain cancer	0.00287	0.00385	CcSEcCtD
Terazosin—Tinnitus—Temozolomide—brain cancer	0.00286	0.00384	CcSEcCtD
Terazosin—Body temperature increased—Procarbazine—brain cancer	0.00285	0.00383	CcSEcCtD
Terazosin—Abdominal pain—Procarbazine—brain cancer	0.00285	0.00383	CcSEcCtD
Terazosin—Arrhythmia—Carmustine—brain cancer	0.00284	0.00381	CcSEcCtD
Terazosin—Oedema—Hydroxyurea—brain cancer	0.00279	0.00374	CcSEcCtD
Terazosin—ADRA1A—central nervous system—brain cancer	0.00276	0.0108	CbGeAlD
Terazosin—Malnutrition—Carmustine—brain cancer	0.00276	0.00371	CcSEcCtD
Terazosin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00273	0.00367	CcSEcCtD
Terazosin—ADRA1A—cerebellum—brain cancer	0.0027	0.0106	CbGeAlD
Terazosin—Back pain—Carmustine—brain cancer	0.00267	0.00359	CcSEcCtD
Terazosin—Malnutrition—Temozolomide—brain cancer	0.00267	0.00358	CcSEcCtD
Terazosin—KCNH2—central nervous system—brain cancer	0.00267	0.0105	CbGeAlD
Terazosin—Jaundice—Etoposide—brain cancer	0.00267	0.00358	CcSEcCtD
Terazosin—Anorexia—Hydroxyurea—brain cancer	0.00266	0.00357	CcSEcCtD
Terazosin—Hypersensitivity—Procarbazine—brain cancer	0.00266	0.00356	CcSEcCtD
Terazosin—Dysgeusia—Temozolomide—brain cancer	0.00262	0.00351	CcSEcCtD
Terazosin—KCNH2—cerebellum—brain cancer	0.00261	0.0102	CbGeAlD
Terazosin—Vision blurred—Carmustine—brain cancer	0.0026	0.0035	CcSEcCtD
Terazosin—Tremor—Carmustine—brain cancer	0.00259	0.00348	CcSEcCtD
Terazosin—Asthenia—Procarbazine—brain cancer	0.00259	0.00347	CcSEcCtD
Terazosin—Back pain—Temozolomide—brain cancer	0.00258	0.00347	CcSEcCtD
Terazosin—Pruritus—Procarbazine—brain cancer	0.00255	0.00342	CcSEcCtD
Terazosin—Vision blurred—Temozolomide—brain cancer	0.00252	0.00338	CcSEcCtD
Terazosin—Tremor—Temozolomide—brain cancer	0.0025	0.00336	CcSEcCtD
Terazosin—Dyspnoea—Hydroxyurea—brain cancer	0.00249	0.00334	CcSEcCtD
Terazosin—Somnolence—Hydroxyurea—brain cancer	0.00248	0.00333	CcSEcCtD
Terazosin—Ill-defined disorder—Temozolomide—brain cancer	0.00248	0.00333	CcSEcCtD
Terazosin—Diarrhoea—Procarbazine—brain cancer	0.00247	0.00331	CcSEcCtD
Terazosin—Dyspepsia—Hydroxyurea—brain cancer	0.00246	0.0033	CcSEcCtD
Terazosin—Angioedema—Temozolomide—brain cancer	0.00244	0.00328	CcSEcCtD
Terazosin—Decreased appetite—Hydroxyurea—brain cancer	0.00243	0.00326	CcSEcCtD
Terazosin—Malaise—Temozolomide—brain cancer	0.00241	0.00323	CcSEcCtD
Terazosin—Fatigue—Hydroxyurea—brain cancer	0.00241	0.00323	CcSEcCtD
Terazosin—Vertigo—Temozolomide—brain cancer	0.0024	0.00322	CcSEcCtD
Terazosin—Convulsion—Carmustine—brain cancer	0.00239	0.00321	CcSEcCtD
Terazosin—Constipation—Hydroxyurea—brain cancer	0.00239	0.0032	CcSEcCtD
Terazosin—Pain—Hydroxyurea—brain cancer	0.00239	0.0032	CcSEcCtD
Terazosin—Dizziness—Procarbazine—brain cancer	0.00238	0.0032	CcSEcCtD
Terazosin—Palpitations—Temozolomide—brain cancer	0.00236	0.00317	CcSEcCtD
Terazosin—Chest pain—Carmustine—brain cancer	0.00235	0.00316	CcSEcCtD
Terazosin—Myalgia—Carmustine—brain cancer	0.00235	0.00316	CcSEcCtD
Terazosin—Anxiety—Carmustine—brain cancer	0.00234	0.00315	CcSEcCtD
Terazosin—Cough—Temozolomide—brain cancer	0.00233	0.00313	CcSEcCtD
Terazosin—Convulsion—Temozolomide—brain cancer	0.00231	0.00311	CcSEcCtD
Terazosin—Feeling abnormal—Hydroxyurea—brain cancer	0.0023	0.00309	CcSEcCtD
Terazosin—Eye disorder—Etoposide—brain cancer	0.00229	0.00308	CcSEcCtD
Terazosin—Vomiting—Procarbazine—brain cancer	0.00229	0.00308	CcSEcCtD
Terazosin—Confusional state—Carmustine—brain cancer	0.00227	0.00305	CcSEcCtD
Terazosin—Myalgia—Temozolomide—brain cancer	0.00227	0.00305	CcSEcCtD
Terazosin—Arthralgia—Temozolomide—brain cancer	0.00227	0.00305	CcSEcCtD
Terazosin—Rash—Procarbazine—brain cancer	0.00227	0.00305	CcSEcCtD
Terazosin—Dermatitis—Procarbazine—brain cancer	0.00227	0.00305	CcSEcCtD
Terazosin—Anxiety—Temozolomide—brain cancer	0.00227	0.00304	CcSEcCtD
Terazosin—Headache—Procarbazine—brain cancer	0.00226	0.00303	CcSEcCtD
Terazosin—Oedema—Carmustine—brain cancer	0.00226	0.00303	CcSEcCtD
Terazosin—Discomfort—Temozolomide—brain cancer	0.00225	0.00302	CcSEcCtD
Terazosin—Dry mouth—Temozolomide—brain cancer	0.00222	0.00298	CcSEcCtD
Terazosin—Thrombocytopenia—Carmustine—brain cancer	0.00221	0.00296	CcSEcCtD
Terazosin—Body temperature increased—Hydroxyurea—brain cancer	0.00221	0.00296	CcSEcCtD
Terazosin—Tachycardia—Carmustine—brain cancer	0.0022	0.00295	CcSEcCtD
Terazosin—Confusional state—Temozolomide—brain cancer	0.0022	0.00295	CcSEcCtD
Terazosin—ADRA1A—brain—brain cancer	0.00219	0.00861	CbGeAlD
Terazosin—Anaphylactic shock—Temozolomide—brain cancer	0.00218	0.00293	CcSEcCtD
Terazosin—Oedema—Temozolomide—brain cancer	0.00218	0.00293	CcSEcCtD
Terazosin—Anorexia—Carmustine—brain cancer	0.00215	0.00289	CcSEcCtD
Terazosin—Nausea—Procarbazine—brain cancer	0.00214	0.00287	CcSEcCtD
Terazosin—Thrombocytopenia—Temozolomide—brain cancer	0.00213	0.00286	CcSEcCtD
Terazosin—KCNH2—brain—brain cancer	0.00212	0.00831	CbGeAlD
Terazosin—Hypotension—Carmustine—brain cancer	0.00211	0.00283	CcSEcCtD
Terazosin—Hyperhidrosis—Temozolomide—brain cancer	0.00211	0.00283	CcSEcCtD
Terazosin—Dysgeusia—Etoposide—brain cancer	0.00209	0.00281	CcSEcCtD
Terazosin—Anorexia—Temozolomide—brain cancer	0.00208	0.00279	CcSEcCtD
Terazosin—Back pain—Etoposide—brain cancer	0.00207	0.00277	CcSEcCtD
Terazosin—ABCB1—telencephalon—brain cancer	0.00206	0.00808	CbGeAlD
Terazosin—Hypersensitivity—Hydroxyurea—brain cancer	0.00206	0.00276	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00205	0.00276	CcSEcCtD
Terazosin—Insomnia—Carmustine—brain cancer	0.00204	0.00274	CcSEcCtD
Terazosin—Paraesthesia—Carmustine—brain cancer	0.00203	0.00272	CcSEcCtD
Terazosin—Dyspnoea—Carmustine—brain cancer	0.00201	0.0027	CcSEcCtD
Terazosin—Somnolence—Carmustine—brain cancer	0.00201	0.00269	CcSEcCtD
Terazosin—Asthenia—Hydroxyurea—brain cancer	0.002	0.00269	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00199	0.00267	CcSEcCtD
Terazosin—Ill-defined disorder—Etoposide—brain cancer	0.00198	0.00266	CcSEcCtD
Terazosin—Insomnia—Temozolomide—brain cancer	0.00197	0.00265	CcSEcCtD
Terazosin—Decreased appetite—Carmustine—brain cancer	0.00196	0.00263	CcSEcCtD
Terazosin—Paraesthesia—Temozolomide—brain cancer	0.00196	0.00263	CcSEcCtD
Terazosin—Dyspnoea—Temozolomide—brain cancer	0.00194	0.00261	CcSEcCtD
Terazosin—Somnolence—Temozolomide—brain cancer	0.00194	0.0026	CcSEcCtD
Terazosin—Constipation—Carmustine—brain cancer	0.00193	0.00259	CcSEcCtD
Terazosin—Pain—Carmustine—brain cancer	0.00193	0.00259	CcSEcCtD
Terazosin—Malaise—Etoposide—brain cancer	0.00193	0.00259	CcSEcCtD
Terazosin—Vertigo—Etoposide—brain cancer	0.00192	0.00258	CcSEcCtD
Terazosin—Dyspepsia—Temozolomide—brain cancer	0.00192	0.00258	CcSEcCtD
Terazosin—Diarrhoea—Hydroxyurea—brain cancer	0.00191	0.00256	CcSEcCtD
Terazosin—Decreased appetite—Temozolomide—brain cancer	0.00189	0.00254	CcSEcCtD
Terazosin—Fatigue—Temozolomide—brain cancer	0.00188	0.00252	CcSEcCtD
Terazosin—Loss of consciousness—Etoposide—brain cancer	0.00188	0.00252	CcSEcCtD
Terazosin—Cough—Etoposide—brain cancer	0.00186	0.0025	CcSEcCtD
Terazosin—Pain—Temozolomide—brain cancer	0.00186	0.0025	CcSEcCtD
Terazosin—Constipation—Temozolomide—brain cancer	0.00186	0.0025	CcSEcCtD
Terazosin—Feeling abnormal—Carmustine—brain cancer	0.00186	0.00249	CcSEcCtD
Terazosin—Convulsion—Etoposide—brain cancer	0.00185	0.00249	CcSEcCtD
Terazosin—Dizziness—Hydroxyurea—brain cancer	0.00185	0.00248	CcSEcCtD
Terazosin—Gastrointestinal pain—Carmustine—brain cancer	0.00184	0.00248	CcSEcCtD
Terazosin—Chest pain—Etoposide—brain cancer	0.00182	0.00244	CcSEcCtD
Terazosin—Discomfort—Etoposide—brain cancer	0.0018	0.00241	CcSEcCtD
Terazosin—Feeling abnormal—Temozolomide—brain cancer	0.0018	0.00241	CcSEcCtD
Terazosin—Body temperature increased—Carmustine—brain cancer	0.00178	0.00239	CcSEcCtD
Terazosin—Abdominal pain—Carmustine—brain cancer	0.00178	0.00239	CcSEcCtD
Terazosin—Gastrointestinal pain—Temozolomide—brain cancer	0.00178	0.00239	CcSEcCtD
Terazosin—Vomiting—Hydroxyurea—brain cancer	0.00177	0.00238	CcSEcCtD
Terazosin—Rash—Hydroxyurea—brain cancer	0.00176	0.00236	CcSEcCtD
Terazosin—Confusional state—Etoposide—brain cancer	0.00176	0.00236	CcSEcCtD
Terazosin—Dermatitis—Hydroxyurea—brain cancer	0.00176	0.00236	CcSEcCtD
Terazosin—Headache—Hydroxyurea—brain cancer	0.00175	0.00235	CcSEcCtD
Terazosin—Anaphylactic shock—Etoposide—brain cancer	0.00174	0.00234	CcSEcCtD
Terazosin—Body temperature increased—Temozolomide—brain cancer	0.00172	0.00231	CcSEcCtD
Terazosin—Abdominal pain—Temozolomide—brain cancer	0.00172	0.00231	CcSEcCtD
Terazosin—ABCB1—gonad—brain cancer	0.00172	0.00674	CbGeAlD
Terazosin—Thrombocytopenia—Etoposide—brain cancer	0.00171	0.00229	CcSEcCtD
Terazosin—Tachycardia—Etoposide—brain cancer	0.0017	0.00228	CcSEcCtD
Terazosin—Hyperhidrosis—Etoposide—brain cancer	0.00169	0.00226	CcSEcCtD
Terazosin—ABCB1—pituitary gland—brain cancer	0.00168	0.00658	CbGeAlD
Terazosin—Anorexia—Etoposide—brain cancer	0.00166	0.00223	CcSEcCtD
Terazosin—Hypersensitivity—Carmustine—brain cancer	0.00166	0.00223	CcSEcCtD
Terazosin—Nausea—Hydroxyurea—brain cancer	0.00166	0.00222	CcSEcCtD
Terazosin—Hypotension—Etoposide—brain cancer	0.00163	0.00219	CcSEcCtD
Terazosin—ABCB1—medulla oblongata—brain cancer	0.00162	0.00635	CbGeAlD
Terazosin—Asthenia—Carmustine—brain cancer	0.00162	0.00217	CcSEcCtD
Terazosin—Hypersensitivity—Temozolomide—brain cancer	0.00161	0.00216	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—brain cancer	0.00157	0.0021	CcSEcCtD
Terazosin—Asthenia—Temozolomide—brain cancer	0.00156	0.0021	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—brain cancer	0.00155	0.00209	CcSEcCtD
Terazosin—Somnolence—Etoposide—brain cancer	0.00155	0.00208	CcSEcCtD
Terazosin—Diarrhoea—Carmustine—brain cancer	0.00154	0.00207	CcSEcCtD
Terazosin—Pruritus—Temozolomide—brain cancer	0.00154	0.00207	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—brain cancer	0.00152	0.00203	CcSEcCtD
Terazosin—Fatigue—Etoposide—brain cancer	0.0015	0.00202	CcSEcCtD
Terazosin—Dizziness—Carmustine—brain cancer	0.00149	0.002	CcSEcCtD
Terazosin—Pain—Etoposide—brain cancer	0.00149	0.002	CcSEcCtD
Terazosin—Constipation—Etoposide—brain cancer	0.00149	0.002	CcSEcCtD
Terazosin—Diarrhoea—Temozolomide—brain cancer	0.00149	0.002	CcSEcCtD
Terazosin—ABCB1—midbrain—brain cancer	0.00148	0.0058	CbGeAlD
Terazosin—ABCB1—spinal cord—brain cancer	0.00144	0.00566	CbGeAlD
Terazosin—Dizziness—Temozolomide—brain cancer	0.00144	0.00193	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—brain cancer	0.00144	0.00193	CcSEcCtD
Terazosin—Vomiting—Carmustine—brain cancer	0.00143	0.00192	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—brain cancer	0.00143	0.00191	CcSEcCtD
Terazosin—Rash—Carmustine—brain cancer	0.00142	0.00191	CcSEcCtD
Terazosin—Dermatitis—Carmustine—brain cancer	0.00142	0.00191	CcSEcCtD
Terazosin—Headache—Carmustine—brain cancer	0.00141	0.0019	CcSEcCtD
Terazosin—Vomiting—Temozolomide—brain cancer	0.00139	0.00186	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—brain cancer	0.00138	0.00185	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—brain cancer	0.00138	0.00185	CcSEcCtD
Terazosin—Rash—Temozolomide—brain cancer	0.00137	0.00184	CcSEcCtD
Terazosin—Dermatitis—Temozolomide—brain cancer	0.00137	0.00184	CcSEcCtD
Terazosin—Headache—Temozolomide—brain cancer	0.00137	0.00183	CcSEcCtD
Terazosin—Nausea—Carmustine—brain cancer	0.00134	0.0018	CcSEcCtD
Terazosin—ABCB1—endocrine gland—brain cancer	0.0013	0.0051	CbGeAlD
Terazosin—Nausea—Temozolomide—brain cancer	0.00129	0.00174	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—brain cancer	0.00129	0.00172	CcSEcCtD
Terazosin—ABCB1—head—brain cancer	0.00128	0.00503	CbGeAlD
Terazosin—Asthenia—Etoposide—brain cancer	0.00125	0.00168	CcSEcCtD
Terazosin—Pruritus—Etoposide—brain cancer	0.00123	0.00166	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—brain cancer	0.00119	0.0016	CcSEcCtD
Terazosin—ABCB1—central nervous system—brain cancer	0.00117	0.00459	CbGeAlD
Terazosin—Dizziness—Etoposide—brain cancer	0.00115	0.00155	CcSEcCtD
Terazosin—ABCB1—cerebellum—brain cancer	0.00114	0.00449	CbGeAlD
Terazosin—Vomiting—Etoposide—brain cancer	0.00111	0.00149	CcSEcCtD
Terazosin—Rash—Etoposide—brain cancer	0.0011	0.00148	CcSEcCtD
Terazosin—Dermatitis—Etoposide—brain cancer	0.0011	0.00147	CcSEcCtD
Terazosin—Headache—Etoposide—brain cancer	0.00109	0.00147	CcSEcCtD
Terazosin—Nausea—Etoposide—brain cancer	0.00104	0.00139	CcSEcCtD
Terazosin—ABCB1—brain—brain cancer	0.00093	0.00365	CbGeAlD
